In young and older adults, intranasal oxytocin lowered resting-state connectivity of the left amygdala within the ventral salience network versus placebo.
In plain wordsIn young and older adults, intranasal oxytocin lowered brain connectivity between the left amygdala and a salience network compared with placebo.
- Peptide
- Oxytocin
- Outcome
- DecreaseWithin-network functional connectivity, left amygdala in ventral salience network
- Study
n = 85
- Comparator
- Placebo
- Outcome group
- Brain and neuronal activity · Nervous system and cognition
- Studied dose
- Dose not stated · intranasalAs given in this study (human).
Source sentences
individuals in the oxytocin compared to the placebo group had lower within-network resting-state functional connectivity, both for left amygdala (MNI coordinates: x = -18, y = 0, z = -15; corrected p < 0.05) within a more ventral salience network
1 context sentence(design, population, supporting numbers)
To address this research gap, 42 young (22.52 ± 3.02 years; 24 in the oxytocin group) and 43 older (71.12 ± 5.25 years; 21 in the oxytocin group) participants were randomized to either self-administer intranasal oxytocin or placebo prior to resting-state functional imaging.